Cargando…

Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease

Anti-proliferative agents have been the primary therapeutic drug of choice to inhibit restenosis after endovascular treatment. However, recent safety and efficacy concerns for patients who underwent peripheral artery disease revascularization have demonstrated the need for alternative therapeutics....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yazdani, Saami K., Lei, Beilei, Cawthon, Claire V., Cooper, Kathryn, Huett, Clifton, Giangrande, Paloma H., Miller, Francis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403884/ https://www.ncbi.nlm.nih.gov/pubmed/36090749 http://dx.doi.org/10.1016/j.omtn.2022.08.007

Ejemplares similares

Smooth muscle cell-targeted RNA ligand promotes accelerated reendothelialization in a swine peripheral injury model
por: Lei, Beilei, et al.
Publicado: (2023)

Pre-Clinical Investigation of Liquid Paclitaxel for Local Drug Delivery: A Pilot Study
por: Cawthon, Claire V., et al.
Publicado: (2020)

TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation
por: Wu, Lian-pan, et al.
Publicado: (2019)

Bilirubin Inhibits Neointima Formation and Vascular Smooth Muscle Cell Proliferation and Migration
por: Peyton, Kelly J., et al.
Publicado: (2012)

Previously differentiated medial vascular smooth muscle cells contribute to neointima formation following vascular injury
por: Herring, Brian Paul, et al.
Publicado: (2014)

Role of FOXM1 in vascular smooth muscle cell survival and neointima formation following vascular injury
por: Franco, Sarah, et al.
Publicado: (2020)

The Development of an ex vivo Flow System to Assess Acute Arterial Drug Retention of Cardiovascular Intravascular Devices
por: Cooper, Kathryn, et al.
Publicado: (2021)

Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation
por: Daniel, Jan-Marcus, et al.
Publicado: (2012)

Gastrodin inhibits cell proliferation in vascular smooth muscle cells and attenuates neointima formation in vivo
por: ZHU, LIHUA, et al.
Publicado: (2012)

Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis
por: Grootaert, Mandy OJ, et al.
Publicado: (2015)

Genistein suppresses leptin‐induced proliferation and migration of vascular smooth muscle cells and neointima formation
por: Tsai, Yung‐Chieh, et al.
Publicado: (2016)

Interferon Regulatory Factor 7 Protects Against Vascular Smooth Muscle Cell Proliferation and Neointima Formation
por: Huang, Ling, et al.
Publicado: (2014)

Xanthohumol Blocks Proliferation and Migration of Vascular Smooth Muscle Cells in Vitro and Reduces Neointima Formation in Vivo
por: Liu, Rongxia, et al.
Publicado: (2017)

USP10 exacerbates neointima formation by stabilizing Skp2 protein in vascular smooth muscle cells
por: Xia, Xiaohong, et al.
Publicado: (2021)

MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells
por: Filippov, Sergey, et al.
Publicado: (2005)

PDZK1 Prevents Neointima Formation via Suppression of Breakpoint Cluster Region Kinase in Vascular Smooth Muscle
por: Lee, Wan Ru, et al.
Publicado: (2015)

Oxidative stress induces early-onset apoptosis of vascular smooth muscle cells and neointima formation in response to injury
por: Gomez, Camilo, et al.
Publicado: (2015)

miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation
por: Yang, Feng, et al.
Publicado: (2018)

Tollip Negatively Regulates Vascular Smooth Muscle Cell–Mediated Neointima Formation by Suppressing Akt‐Dependent Signaling
por: Zhi, Hong, et al.
Publicado: (2018)

Homer binds to Orai1 and TRPC channels in the neointima and regulates vascular smooth muscle cell migration and proliferation
por: Jia, Shuping, et al.
Publicado: (2017)

Smooth muscle cells-specific loss of OCT4 accelerates neointima formation after acute vascular injury
por: Shin, Junchul, et al.
Publicado: (2023)

Smooth Muscle–Selective Inhibition of Nuclear Factor‐κB Attenuates Smooth Muscle Phenotypic Switching and Neointima Formation Following Vascular Injury
por: Yoshida, Tadashi, et al.
Publicado: (2013)

Delivery of Cell-Specific Aptamers to the Arterial Wall with an Occlusion Perfusion Catheter
por: Udofot, Ofonime, et al.
Publicado: (2019)

Vascular Adventitial Fibroblasts-Derived FGF10 Promotes Vascular Smooth Muscle Cells Proliferation and Migration in vitro and the Neointima Formation in vivo
por: Chen, Yuhan, et al.
Publicado: (2021)

Poldip2 Knockdown Inhibits Vascular Smooth Muscle Proliferation and Neointima Formation by Regulating the Expression of PCNA and p21
por: Datla, Srinivasa Raju, et al.
Publicado: (2018)

Adipose differentiation-related protein knockdown inhibits vascular smooth muscle cell proliferation and migration and attenuates neointima formation
por: Zhao, Haomin, et al.
Publicado: (2017)

Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell‐Derived Chemokine (C‐C Motif) Ligand 2 and Chemokine (C‐X‐C motif) Ligand 1 Contributes to Neointima Formation
por: Yu, Baoqi, et al.
Publicado: (2016)

3,3′Diindolylmethane Suppresses Vascular Smooth Muscle Cell Phenotypic Modulation and Inhibits Neointima Formation after Carotid Injury
por: Guan, Hongjing, et al.
Publicado: (2012)

S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo
por: Wu, Yih-Jer, et al.
Publicado: (2009)

circ-Sirt1 Decelerates Senescence by Inhibiting p53 Activation in Vascular Smooth Muscle Cells, Ameliorating Neointima Formation
por: Kong, Peng, et al.
Publicado: (2021)

DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation
por: Kumar, Sudeep, et al.
Publicado: (2022)

BACH1 deficiency prevents neointima formation and maintains the differentiated phenotype of vascular smooth muscle cells by regulating chromatin accessibility
por: Guo, Jieyu, et al.
Publicado: (2023)

NF2 deficiency accelerates neointima hyperplasia following vascular injury via promoting YAP-TEAD1 interaction in vascular smooth muscle cells
por: Sun, Xiongshan, et al.
Publicado: (2020)

NCK Associated Protein 1 Modulated by miRNA‐214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia
por: Afzal, Tayyab Adeel, et al.
Publicado: (2016)

Myotubularin‐Related Protein14 Prevents Neointima Formation and Vascular Smooth Muscle Cell Proliferation by Inhibiting Polo‐Like Kinase1
por: Kong, Ling‐Yao, et al.
Publicado: (2022)

Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima
por: Hwang, Ae-Rang, et al.
Publicado: (2023)

In vivo studies on intraluminal pressure variations in the porcine oviductal isthmus /
por: Pettersson, Ann
Publicado: (1992)

Empagliflozin prevents neointima formation by impairing smooth muscle cell proliferation and accelerating endothelial regeneration
por: Dutzmann, Jochen, et al.
Publicado: (2022)

Novel Pathological Role of hnRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) in Vascular Smooth Muscle Cell Function and Neointima Hyperplasia
por: Zhang, Li, et al.
Publicado: (2017)

Small molecule-mediated induction of miR-9 suppressed vascular smooth muscle cell proliferation and neointima formation after balloon injury
por: Ham, Onju, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bc6cie74srah91ir4t27n8qgmk